Todd Golub currently serves as a scientific advisor to the following companies:
Anji Pharmaceuticals, Inc (compensation consisting of cash and equity)
Braidwell (compensation consisting of cash)
Dewpoint Therapeutics (compensation consisting of cash and equity)
Amplifyer Bio, Inc (compensation consisting of equity)
He is also a co-founder (and holds equity in) Sherlock Biosciences, Inc., and was previously a scientific advisor to the company.
Dr. Golub is also affiliated with a number of non-profit organizations, serving on the Board of Directors of the Damon Runyon Cancer Research Foundation, the Board of Trustees of the Boston Symphony Orchestra, the Board of Directors of the Gene Lay Institute, and the Project Liberty Board of Stewards.
Dr. Golub may receive honoraria and travel reimbursements for speaking engagements and other activities. He is a co-inventor on patents related to his research, some of which have been licensed to companies, including those listed above.
Dr. Golub receives research funding for his laboratory from Calico Life Sciences and Deerfield Management.